Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy

Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy

Abstract Background People who inject drugs (PWID) constitute 60% of the approximately 5 million people in the U.S. infected with hepatitis C virus (HCV). Treatment of PWID is complex due to addiction, mental illness, poverty, homelessness, lack of positive social support, poor adherence-related ski...

Full description

Bibliographic Details
Main Authors: Matthew J. Akiyama, Linda Agyemang, Julia H. Arnsten, Moonseong Heo, Brianna L. Norton, Bruce R. Schackman, Benjamin P. Linas, Alain H. Litwin
Format: Article
Language:English
Published: BMC 2018-02-01
Series:BMC Infectious Diseases
Subjects:
Hepatitis C virus
Injection drug use
People who inject drugs
Directly observed therapy
Group treatment
Models of care
Online Access:http://link.springer.com/article/10.1186/s12879-018-2964-5

Internet

http://link.springer.com/article/10.1186/s12879-018-2964-5

Similar Items